Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus.

Serena Fasano,Valentina Messiniti,Michele Iudici,Melania Alessia Coscia,Francesco Ciccia

Lupus science & medicine（2023）

引用 2|浏览3

暂无评分

摘要

Patients with low oral HCQ dosage tend to have more flares, although the difference was not statistically significant. Higher HCQ blood levels were protective against flare occurrence. The risks and benefits must be balanced in choosing HCQ dose.

查看译文

关键词

Antirheumatic Agents,Autoimmune Diseases,Systemic Lupus Erythematosus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要